SPI1 and age-related macular degeneration: Through gene knockdown experiments targeting Spi1 in BMDM and CNV mice, we observed a significant inhibition of macrophage M1 polarization and a reduction in neovascularization, suggesting it as a potential therapeutic target for AMD.